nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CYP2D6—breast cancer	0.0939	0.389	CbGaD
Pimozide—CYP3A4—breast cancer	0.0805	0.333	CbGaD
Pimozide—ABCB1—breast cancer	0.067	0.278	CbGaD
Pimozide—HTR6—Raloxifene—breast cancer	0.0462	0.102	CbGbCtD
Pimozide—CYP1A2—Anastrozole—breast cancer	0.0193	0.0427	CbGbCtD
Pimozide—CYP1A2—Toremifene—breast cancer	0.0177	0.039	CbGbCtD
Pimozide—CYP3A5—Lapatinib—breast cancer	0.0173	0.0383	CbGbCtD
Pimozide—ABCB1—Toremifene—breast cancer	0.0155	0.0341	CbGbCtD
Pimozide—CYP2C19—Lapatinib—breast cancer	0.014	0.0309	CbGbCtD
Pimozide—CYP3A4—Exemestane—breast cancer	0.0134	0.0295	CbGbCtD
Pimozide—CYP2D6—Idarubicin—breast cancer	0.0121	0.0267	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.0116	0.0255	CbGbCtD
Pimozide—CYP3A7—Tamoxifen—breast cancer	0.0116	0.0255	CbGbCtD
Pimozide—CYP3A4—Letrozole—breast cancer	0.0114	0.0251	CbGbCtD
Pimozide—ABCB1—Lapatinib—breast cancer	0.0113	0.0249	CbGbCtD
Pimozide—CYP2E1—Tamoxifen—breast cancer	0.0112	0.0247	CbGbCtD
Pimozide—CYP2E1—Mitoxantrone—breast cancer	0.0109	0.024	CbGbCtD
Pimozide—CYP3A4—Anastrozole—breast cancer	0.0101	0.0224	CbGbCtD
Pimozide—CYP3A4—Toremifene—breast cancer	0.00926	0.0205	CbGbCtD
Pimozide—CYP3A7—Paclitaxel—breast cancer	0.009	0.0199	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.009	0.0199	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00888	0.0196	CbGbCtD
Pimozide—CYP3A7—Irinotecan—breast cancer	0.00888	0.0196	CbGbCtD
Pimozide—CYP3A5—Tamoxifen—breast cancer	0.00867	0.0192	CbGbCtD
Pimozide—CYP3A4—Fulvestrant—breast cancer	0.00861	0.019	CbGbCtD
Pimozide—CYP3A4—Thiotepa—breast cancer	0.00767	0.0169	CbGbCtD
Pimozide—CYP3A4—Ixabepilone—breast cancer	0.00702	0.0155	CbGbCtD
Pimozide—CYP2C19—Tamoxifen—breast cancer	0.007	0.0155	CbGbCtD
Pimozide—CYP3A4—Lapatinib—breast cancer	0.00675	0.0149	CbGbCtD
Pimozide—CYP3A5—Paclitaxel—breast cancer	0.00675	0.0149	CbGbCtD
Pimozide—CYP3A5—Irinotecan—breast cancer	0.00666	0.0147	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00651	0.0144	CbGbCtD
Pimozide—CYP3A7—Docetaxel—breast cancer	0.00651	0.0144	CbGbCtD
Pimozide—CYP1A2—Tamoxifen—breast cancer	0.00646	0.0143	CbGbCtD
Pimozide—ABCB1—Vinorelbine—breast cancer	0.00625	0.0138	CbGbCtD
Pimozide—CYP2D6—Vinorelbine—breast cancer	0.00589	0.013	CbGbCtD
Pimozide—ABCB1—Tamoxifen—breast cancer	0.00565	0.0125	CbGbCtD
Pimozide—ABCB1—Mitoxantrone—breast cancer	0.00551	0.0122	CbGbCtD
Pimozide—CYP2D6—Tamoxifen—breast cancer	0.00532	0.0117	CbGbCtD
Pimozide—CYP3A4—Raloxifene—breast cancer	0.00512	0.0113	CbGbCtD
Pimozide—CYP3A5—Docetaxel—breast cancer	0.00488	0.0108	CbGbCtD
Pimozide—ABCB1—Gemcitabine—breast cancer	0.00486	0.0107	CbGbCtD
Pimozide—CYP1A2—Fluorouracil—breast cancer	0.00476	0.0105	CbGbCtD
Pimozide—ABCB1—Paclitaxel—breast cancer	0.00439	0.0097	CbGbCtD
Pimozide—ABCB1—Irinotecan—breast cancer	0.00433	0.00957	CbGbCtD
Pimozide—ABCB1—Vinblastine—breast cancer	0.00385	0.00851	CbGbCtD
Pimozide—CYP3A4—Vinorelbine—breast cancer	0.00375	0.00828	CbGbCtD
Pimozide—CYP2D6—Vinblastine—breast cancer	0.00363	0.00802	CbGbCtD
Pimozide—CYP3A4—Tamoxifen—breast cancer	0.00338	0.00747	CbGbCtD
Pimozide—CYP3A4—Mitoxantrone—breast cancer	0.0033	0.00729	CbGbCtD
Pimozide—ABCB1—Docetaxel—breast cancer	0.00318	0.00702	CbGbCtD
Pimozide—CYP3A4—Paclitaxel—breast cancer	0.00263	0.00581	CbGbCtD
Pimozide—CYP3A4—Irinotecan—breast cancer	0.0026	0.00574	CbGbCtD
Pimozide—ABCB1—Doxorubicin—breast cancer	0.00237	0.00523	CbGbCtD
Pimozide—CYP3A4—Vinblastine—breast cancer	0.00231	0.0051	CbGbCtD
Pimozide—ABCB1—Methotrexate—breast cancer	0.00229	0.00507	CbGbCtD
Pimozide—CYP2D6—Doxorubicin—breast cancer	0.00223	0.00493	CbGbCtD
Pimozide—CYP3A4—Docetaxel—breast cancer	0.0019	0.0042	CbGbCtD
Pimozide—CYP3A4—Doxorubicin—breast cancer	0.00142	0.00313	CbGbCtD
Pimozide—CALM3—mammary gland—breast cancer	0.000872	0.0322	CbGeAlD
Pimozide—Ezetimibe—SLCO1B1—breast cancer	0.000753	0.213	CrCbGaD
Pimozide—CALM3—nipple—breast cancer	0.000722	0.0266	CbGeAlD
Pimozide—CALM1—mammary gland—breast cancer	0.000682	0.0252	CbGeAlD
Pimozide—CALM2—nipple—breast cancer	0.000567	0.0209	CbGeAlD
Pimozide—CALM1—nipple—breast cancer	0.000564	0.0208	CbGeAlD
Pimozide—OPRK1—female reproductive system—breast cancer	0.000549	0.0203	CbGeAlD
Pimozide—Fexofenadine—SLCO1B1—breast cancer	0.000537	0.151	CrCbGaD
Pimozide—KCNH2—nipple—breast cancer	0.000513	0.019	CbGeAlD
Pimozide—CYP3A7—endocrine gland—breast cancer	0.00051	0.0188	CbGeAlD
Pimozide—CALM2—embryo—breast cancer	0.000468	0.0173	CbGeAlD
Pimozide—CALM1—embryo—breast cancer	0.000465	0.0172	CbGeAlD
Pimozide—CYP1A2—nipple—breast cancer	0.000439	0.0162	CbGeAlD
Pimozide—CALM3—endometrium—breast cancer	0.000436	0.0161	CbGeAlD
Pimozide—HRH1—nipple—breast cancer	0.000411	0.0152	CbGeAlD
Pimozide—CALM3—uterus—breast cancer	0.000401	0.0148	CbGeAlD
Pimozide—CALM3—pituitary gland—breast cancer	0.000394	0.0146	CbGeAlD
Pimozide—CALM3—adipose tissue—breast cancer	0.000393	0.0145	CbGeAlD
Pimozide—CALM2—epithelium—breast cancer	0.000382	0.0141	CbGeAlD
Pimozide—CALM1—epithelium—breast cancer	0.00038	0.014	CbGeAlD
Pimozide—CALM2—skin of body—breast cancer	0.000363	0.0134	CbGeAlD
Pimozide—CALM1—skin of body—breast cancer	0.000361	0.0133	CbGeAlD
Pimozide—CALM3—adrenal gland—breast cancer	0.000352	0.013	CbGeAlD
Pimozide—CALM2—endometrium—breast cancer	0.000342	0.0126	CbGeAlD
Pimozide—CALM3—bone marrow—breast cancer	0.000341	0.0126	CbGeAlD
Pimozide—CALM1—endometrium—breast cancer	0.000341	0.0126	CbGeAlD
Pimozide—OPRM1—endocrine gland—breast cancer	0.00033	0.0122	CbGeAlD
Pimozide—CALM3—female gonad—breast cancer	0.000328	0.0121	CbGeAlD
Pimozide—Ezetimibe—ABCG2—breast cancer	0.000328	0.0925	CrCbGaD
Pimozide—CALM2—uterus—breast cancer	0.000315	0.0116	CbGeAlD
Pimozide—CALM1—uterus—breast cancer	0.000314	0.0116	CbGeAlD
Pimozide—KCNH2—endometrium—breast cancer	0.00031	0.0114	CbGeAlD
Pimozide—CALM2—pituitary gland—breast cancer	0.00031	0.0114	CbGeAlD
Pimozide—CALM2—adipose tissue—breast cancer	0.000308	0.0114	CbGeAlD
Pimozide—CALM1—pituitary gland—breast cancer	0.000308	0.0114	CbGeAlD
Pimozide—CALM1—adipose tissue—breast cancer	0.000307	0.0113	CbGeAlD
Pimozide—CHRM2—endocrine gland—breast cancer	0.000301	0.0111	CbGeAlD
Pimozide—KCNH2—uterus—breast cancer	0.000286	0.0105	CbGeAlD
Pimozide—DRD2—pituitary gland—breast cancer	0.000285	0.0105	CbGeAlD
Pimozide—HTR2A—embryo—breast cancer	0.000283	0.0105	CbGeAlD
Pimozide—CALM2—female reproductive system—breast cancer	0.000283	0.0105	CbGeAlD
Pimozide—CALM1—female reproductive system—breast cancer	0.000282	0.0104	CbGeAlD
Pimozide—HTR1A—adrenal gland—breast cancer	0.000281	0.0104	CbGeAlD
Pimozide—KCNH2—pituitary gland—breast cancer	0.00028	0.0104	CbGeAlD
Pimozide—HRH1—epithelium—breast cancer	0.000277	0.0102	CbGeAlD
Pimozide—CALM2—adrenal gland—breast cancer	0.000277	0.0102	CbGeAlD
Pimozide—CALM1—adrenal gland—breast cancer	0.000275	0.0102	CbGeAlD
Pimozide—CALM2—bone marrow—breast cancer	0.000268	0.00988	CbGeAlD
Pimozide—CALM1—bone marrow—breast cancer	0.000266	0.00984	CbGeAlD
Pimozide—CALM2—female gonad—breast cancer	0.000258	0.00952	CbGeAlD
Pimozide—KCNH2—female reproductive system—breast cancer	0.000257	0.00948	CbGeAlD
Pimozide—CALM1—female gonad—breast cancer	0.000257	0.00948	CbGeAlD
Pimozide—KCNH2—adrenal gland—breast cancer	0.000251	0.00925	CbGeAlD
Pimozide—HRH1—endometrium—breast cancer	0.000248	0.00917	CbGeAlD
Pimozide—HTR1A—endocrine gland—breast cancer	0.000244	0.00901	CbGeAlD
Pimozide—KCNH2—bone marrow—breast cancer	0.000242	0.00895	CbGeAlD
Pimozide—CALM2—endocrine gland—breast cancer	0.00024	0.00886	CbGeAlD
Pimozide—CALM1—endocrine gland—breast cancer	0.000239	0.00882	CbGeAlD
Pimozide—KCNH2—female gonad—breast cancer	0.000234	0.00863	CbGeAlD
Pimozide—HTR2A—epithelium—breast cancer	0.000231	0.00854	CbGeAlD
Pimozide—CYP3A5—adipose tissue—breast cancer	0.000231	0.00852	CbGeAlD
Pimozide—CYP2C19—endocrine gland—breast cancer	0.000228	0.00841	CbGeAlD
Pimozide—HRH1—adipose tissue—breast cancer	0.000224	0.00827	CbGeAlD
Pimozide—DRD2—endocrine gland—breast cancer	0.00022	0.00814	CbGeAlD
Pimozide—KCNH2—endocrine gland—breast cancer	0.000217	0.00802	CbGeAlD
Pimozide—CALM3—lymph node—breast cancer	0.000211	0.0078	CbGeAlD
Pimozide—HRH1—female reproductive system—breast cancer	0.000206	0.0076	CbGeAlD
Pimozide—HRH1—adrenal gland—breast cancer	0.000201	0.00742	CbGeAlD
Pimozide—CYP2E1—female reproductive system—breast cancer	0.000198	0.0073	CbGeAlD
Pimozide—CYP2E1—adrenal gland—breast cancer	0.000193	0.00713	CbGeAlD
Pimozide—CYP3A5—female gonad—breast cancer	0.000193	0.00712	CbGeAlD
Pimozide—Astemizole—CYP2D6—breast cancer	0.000191	0.0539	CrCbGaD
Pimozide—HTR2A—pituitary gland—breast cancer	0.000188	0.00693	CbGeAlD
Pimozide—HRH1—female gonad—breast cancer	0.000187	0.00692	CbGeAlD
Pimozide—CYP1A2—endocrine gland—breast cancer	0.000186	0.00687	CbGeAlD
Pimozide—ABCB1—embryo—breast cancer	0.000186	0.00686	CbGeAlD
Pimozide—CYP3A5—endocrine gland—breast cancer	0.000179	0.00663	CbGeAlD
Pimozide—HRH1—endocrine gland—breast cancer	0.000174	0.00643	CbGeAlD
Pimozide—HTR2A—female reproductive system—breast cancer	0.000172	0.00635	CbGeAlD
Pimozide—Sertindole—CYP2D6—breast cancer	0.00017	0.0481	CrCbGaD
Pimozide—HTR2A—adrenal gland—breast cancer	0.000168	0.00619	CbGeAlD
Pimozide—CYP2E1—endocrine gland—breast cancer	0.000167	0.00618	CbGeAlD
Pimozide—CALM2—lymph node—breast cancer	0.000166	0.00612	CbGeAlD
Pimozide—CALM1—lymph node—breast cancer	0.000165	0.0061	CbGeAlD
Pimozide—Astemizole—CYP3A4—breast cancer	0.000164	0.0463	CrCbGaD
Pimozide—Ezetimibe—CYP3A4—breast cancer	0.000164	0.0463	CrCbGaD
Pimozide—CYP3A4—female reproductive system—breast cancer	0.000159	0.00588	CbGeAlD
Pimozide—CYP2D6—female reproductive system—breast cancer	0.000157	0.00578	CbGeAlD
Pimozide—ABCB1—epithelium—breast cancer	0.000152	0.0056	CbGeAlD
Pimozide—Flunarizine—CYP1A1—breast cancer	0.000151	0.0427	CrCbGaD
Pimozide—KCNH2—lymph node—breast cancer	0.00015	0.00555	CbGeAlD
Pimozide—Sertindole—CYP3A4—breast cancer	0.000146	0.0412	CrCbGaD
Pimozide—HTR2A—endocrine gland—breast cancer	0.000145	0.00537	CbGeAlD
Pimozide—CYP2D6—female gonad—breast cancer	0.000142	0.00526	CbGeAlD
Pimozide—Astemizole—ABCB1—breast cancer	0.000136	0.0385	CrCbGaD
Pimozide—Ezetimibe—ABCB1—breast cancer	0.000136	0.0385	CrCbGaD
Pimozide—Fexofenadine—CYP2D6—breast cancer	0.000136	0.0384	CrCbGaD
Pimozide—ABCB1—endometrium—breast cancer	0.000136	0.00502	CbGeAlD
Pimozide—CYP3A4—endocrine gland—breast cancer	0.000135	0.00497	CbGeAlD
Pimozide—CYP2D6—endocrine gland—breast cancer	0.000132	0.00489	CbGeAlD
Pimozide—ABCB1—uterus—breast cancer	0.000125	0.00463	CbGeAlD
Pimozide—Domperidone—CYP2D6—breast cancer	0.000124	0.0351	CrCbGaD
Pimozide—ABCB1—pituitary gland—breast cancer	0.000123	0.00454	CbGeAlD
Pimozide—ABCB1—adipose tissue—breast cancer	0.000123	0.00453	CbGeAlD
Pimozide—HRH1—lymph node—breast cancer	0.00012	0.00445	CbGeAlD
Pimozide—ABCB1—female reproductive system—breast cancer	0.000113	0.00416	CbGeAlD
Pimozide—Flunarizine—CYP2D6—breast cancer	0.000113	0.0318	CrCbGaD
Pimozide—ABCB1—adrenal gland—breast cancer	0.00011	0.00406	CbGeAlD
Pimozide—Domperidone—CYP3A4—breast cancer	0.000107	0.0301	CrCbGaD
Pimozide—ABCB1—bone marrow—breast cancer	0.000106	0.00393	CbGeAlD
Pimozide—ABCB1—female gonad—breast cancer	0.000102	0.00378	CbGeAlD
Pimozide—Fexofenadine—ABCB1—breast cancer	9.72e-05	0.0274	CrCbGaD
Pimozide—ABCB1—endocrine gland—breast cancer	9.53e-05	0.00352	CbGeAlD
Pimozide—Domperidone—ABCB1—breast cancer	8.87e-05	0.025	CrCbGaD
Pimozide—Urticaria—Fluorouracil—breast cancer	6.97e-05	0.000502	CcSEcCtD
Pimozide—Headache—Vinorelbine—breast cancer	6.96e-05	0.000501	CcSEcCtD
Pimozide—Syncope—Docetaxel—breast cancer	6.96e-05	0.000501	CcSEcCtD
Pimozide—Dysphagia—Doxorubicin—breast cancer	6.95e-05	0.000501	CcSEcCtD
Pimozide—Leukopenia—Docetaxel—breast cancer	6.95e-05	0.0005	CcSEcCtD
Pimozide—Anaemia—Capecitabine—breast cancer	6.94e-05	0.0005	CcSEcCtD
Pimozide—Pollakiuria—Epirubicin—breast cancer	6.94e-05	0.0005	CcSEcCtD
Pimozide—Eosinophilia—Doxorubicin—breast cancer	6.88e-05	0.000496	CcSEcCtD
Pimozide—Sweating—Methotrexate—breast cancer	6.86e-05	0.000494	CcSEcCtD
Pimozide—Palpitations—Docetaxel—breast cancer	6.86e-05	0.000494	CcSEcCtD
Pimozide—Weight increased—Epirubicin—breast cancer	6.84e-05	0.000492	CcSEcCtD
Pimozide—Loss of consciousness—Docetaxel—breast cancer	6.82e-05	0.000491	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Paclitaxel—breast cancer	6.81e-05	0.00049	CcSEcCtD
Pimozide—Weight decreased—Epirubicin—breast cancer	6.8e-05	0.000489	CcSEcCtD
Pimozide—Insomnia—Paclitaxel—breast cancer	6.76e-05	0.000487	CcSEcCtD
Pimozide—Vomiting—Thiotepa—breast cancer	6.74e-05	0.000486	CcSEcCtD
Pimozide—Syncope—Capecitabine—breast cancer	6.74e-05	0.000485	CcSEcCtD
Pimozide—Leukopenia—Capecitabine—breast cancer	6.72e-05	0.000484	CcSEcCtD
Pimozide—Convulsion—Docetaxel—breast cancer	6.72e-05	0.000484	CcSEcCtD
Pimozide—Hypertension—Docetaxel—breast cancer	6.7e-05	0.000483	CcSEcCtD
Pimozide—Drowsiness—Epirubicin—breast cancer	6.7e-05	0.000482	CcSEcCtD
Pimozide—Rash—Thiotepa—breast cancer	6.69e-05	0.000482	CcSEcCtD
Pimozide—Dermatitis—Thiotepa—breast cancer	6.68e-05	0.000481	CcSEcCtD
Pimozide—Agranulocytosis—Methotrexate—breast cancer	6.68e-05	0.000481	CcSEcCtD
Pimozide—Headache—Thiotepa—breast cancer	6.65e-05	0.000479	CcSEcCtD
Pimozide—Somnolence—Paclitaxel—breast cancer	6.64e-05	0.000478	CcSEcCtD
Pimozide—Palpitations—Capecitabine—breast cancer	6.64e-05	0.000478	CcSEcCtD
Pimozide—Myalgia—Docetaxel—breast cancer	6.61e-05	0.000476	CcSEcCtD
Pimozide—Chest pain—Docetaxel—breast cancer	6.61e-05	0.000476	CcSEcCtD
Pimozide—Loss of consciousness—Capecitabine—breast cancer	6.6e-05	0.000476	CcSEcCtD
Pimozide—Pancytopenia—Doxorubicin—breast cancer	6.6e-05	0.000475	CcSEcCtD
Pimozide—Nausea—Vinorelbine—breast cancer	6.6e-05	0.000475	CcSEcCtD
Pimozide—ABCB1—lymph node—breast cancer	6.59e-05	0.00243	CbGeAlD
Pimozide—Asthenia—Mitoxantrone—breast cancer	6.57e-05	0.000473	CcSEcCtD
Pimozide—Asthenia—Irinotecan—breast cancer	6.57e-05	0.000473	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	6.56e-05	0.000473	CcSEcCtD
Pimozide—Decreased appetite—Paclitaxel—breast cancer	6.49e-05	0.000468	CcSEcCtD
Pimozide—Hypertension—Capecitabine—breast cancer	6.49e-05	0.000467	CcSEcCtD
Pimozide—Dry mouth—Docetaxel—breast cancer	6.46e-05	0.000465	CcSEcCtD
Pimozide—Gastrointestinal disorder—Paclitaxel—breast cancer	6.45e-05	0.000465	CcSEcCtD
Pimozide—Sweating—Epirubicin—breast cancer	6.42e-05	0.000462	CcSEcCtD
Pimozide—Pollakiuria—Doxorubicin—breast cancer	6.42e-05	0.000462	CcSEcCtD
Pimozide—Asthenia—Gemcitabine—breast cancer	6.4e-05	0.000461	CcSEcCtD
Pimozide—Chest pain—Capecitabine—breast cancer	6.4e-05	0.000461	CcSEcCtD
Pimozide—Myalgia—Capecitabine—breast cancer	6.4e-05	0.000461	CcSEcCtD
Pimozide—Constipation—Paclitaxel—breast cancer	6.39e-05	0.00046	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	6.35e-05	0.000458	CcSEcCtD
Pimozide—Weight increased—Doxorubicin—breast cancer	6.32e-05	0.000456	CcSEcCtD
Pimozide—Pruritus—Gemcitabine—breast cancer	6.31e-05	0.000455	CcSEcCtD
Pimozide—Nausea—Thiotepa—breast cancer	6.3e-05	0.000454	CcSEcCtD
Pimozide—Weight decreased—Doxorubicin—breast cancer	6.29e-05	0.000453	CcSEcCtD
Pimozide—Diarrhoea—Mitoxantrone—breast cancer	6.27e-05	0.000451	CcSEcCtD
Pimozide—Diarrhoea—Irinotecan—breast cancer	6.27e-05	0.000451	CcSEcCtD
Pimozide—Dry mouth—Capecitabine—breast cancer	6.25e-05	0.000451	CcSEcCtD
Pimozide—Agranulocytosis—Epirubicin—breast cancer	6.25e-05	0.00045	CcSEcCtD
Pimozide—Shock—Docetaxel—breast cancer	6.23e-05	0.000449	CcSEcCtD
Pimozide—Nervous system disorder—Docetaxel—breast cancer	6.21e-05	0.000447	CcSEcCtD
Pimozide—Pruritus—Fluorouracil—breast cancer	6.21e-05	0.000447	CcSEcCtD
Pimozide—Drowsiness—Doxorubicin—breast cancer	6.2e-05	0.000446	CcSEcCtD
Pimozide—Visual impairment—Methotrexate—breast cancer	6.19e-05	0.000446	CcSEcCtD
Pimozide—Tachycardia—Docetaxel—breast cancer	6.18e-05	0.000445	CcSEcCtD
Pimozide—Skin disorder—Docetaxel—breast cancer	6.15e-05	0.000443	CcSEcCtD
Pimozide—Diarrhoea—Gemcitabine—breast cancer	6.11e-05	0.00044	CcSEcCtD
Pimozide—Dizziness—Irinotecan—breast cancer	6.06e-05	0.000436	CcSEcCtD
Pimozide—Anorexia—Docetaxel—breast cancer	6.04e-05	0.000435	CcSEcCtD
Pimozide—Shock—Capecitabine—breast cancer	6.03e-05	0.000434	CcSEcCtD
Pimozide—Nervous system disorder—Capecitabine—breast cancer	6.01e-05	0.000433	CcSEcCtD
Pimozide—Eye disorder—Methotrexate—breast cancer	6e-05	0.000432	CcSEcCtD
Pimozide—Diarrhoea—Fluorouracil—breast cancer	6e-05	0.000432	CcSEcCtD
Pimozide—Tachycardia—Capecitabine—breast cancer	5.98e-05	0.000431	CcSEcCtD
Pimozide—Cardiac disorder—Methotrexate—breast cancer	5.96e-05	0.000429	CcSEcCtD
Pimozide—Skin disorder—Capecitabine—breast cancer	5.96e-05	0.000429	CcSEcCtD
Pimozide—Sweating—Doxorubicin—breast cancer	5.94e-05	0.000428	CcSEcCtD
Pimozide—Urticaria—Paclitaxel—breast cancer	5.94e-05	0.000428	CcSEcCtD
Pimozide—Hyperhidrosis—Capecitabine—breast cancer	5.93e-05	0.000427	CcSEcCtD
Pimozide—Hypotension—Docetaxel—breast cancer	5.92e-05	0.000426	CcSEcCtD
Pimozide—Connective tissue disorder—Epirubicin—breast cancer	5.91e-05	0.000426	CcSEcCtD
Pimozide—Anorexia—Capecitabine—breast cancer	5.84e-05	0.000421	CcSEcCtD
Pimozide—Vomiting—Mitoxantrone—breast cancer	5.82e-05	0.00042	CcSEcCtD
Pimozide—Vomiting—Irinotecan—breast cancer	5.82e-05	0.00042	CcSEcCtD
Pimozide—Dizziness—Fluorouracil—breast cancer	5.8e-05	0.000418	CcSEcCtD
Pimozide—Visual impairment—Epirubicin—breast cancer	5.79e-05	0.000417	CcSEcCtD
Pimozide—Agranulocytosis—Doxorubicin—breast cancer	5.78e-05	0.000417	CcSEcCtD
Pimozide—Rash—Irinotecan—breast cancer	5.78e-05	0.000416	CcSEcCtD
Pimozide—Rash—Mitoxantrone—breast cancer	5.78e-05	0.000416	CcSEcCtD
Pimozide—Dermatitis—Mitoxantrone—breast cancer	5.77e-05	0.000416	CcSEcCtD
Pimozide—Dermatitis—Irinotecan—breast cancer	5.77e-05	0.000416	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Docetaxel—breast cancer	5.77e-05	0.000416	CcSEcCtD
Pimozide—Headache—Irinotecan—breast cancer	5.74e-05	0.000413	CcSEcCtD
Pimozide—Headache—Mitoxantrone—breast cancer	5.74e-05	0.000413	CcSEcCtD
Pimozide—Hypotension—Capecitabine—breast cancer	5.73e-05	0.000413	CcSEcCtD
Pimozide—Insomnia—Docetaxel—breast cancer	5.73e-05	0.000413	CcSEcCtD
Pimozide—Vomiting—Gemcitabine—breast cancer	5.67e-05	0.000409	CcSEcCtD
Pimozide—Somnolence—Docetaxel—breast cancer	5.63e-05	0.000406	CcSEcCtD
Pimozide—Mental disorder—Methotrexate—breast cancer	5.63e-05	0.000405	CcSEcCtD
Pimozide—Rash—Gemcitabine—breast cancer	5.63e-05	0.000405	CcSEcCtD
Pimozide—Dermatitis—Gemcitabine—breast cancer	5.62e-05	0.000405	CcSEcCtD
Pimozide—Eye disorder—Epirubicin—breast cancer	5.62e-05	0.000405	CcSEcCtD
Pimozide—Headache—Gemcitabine—breast cancer	5.59e-05	0.000403	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Capecitabine—breast cancer	5.59e-05	0.000402	CcSEcCtD
Pimozide—Cardiac disorder—Epirubicin—breast cancer	5.58e-05	0.000402	CcSEcCtD
Pimozide—Vomiting—Fluorouracil—breast cancer	5.58e-05	0.000402	CcSEcCtD
Pimozide—Insomnia—Capecitabine—breast cancer	5.55e-05	0.000399	CcSEcCtD
Pimozide—Rash—Fluorouracil—breast cancer	5.53e-05	0.000398	CcSEcCtD
Pimozide—Dermatitis—Fluorouracil—breast cancer	5.53e-05	0.000398	CcSEcCtD
Pimozide—Decreased appetite—Docetaxel—breast cancer	5.5e-05	0.000397	CcSEcCtD
Pimozide—Headache—Fluorouracil—breast cancer	5.5e-05	0.000396	CcSEcCtD
Pimozide—Gastrointestinal disorder—Docetaxel—breast cancer	5.47e-05	0.000394	CcSEcCtD
Pimozide—Connective tissue disorder—Doxorubicin—breast cancer	5.47e-05	0.000394	CcSEcCtD
Pimozide—Nausea—Mitoxantrone—breast cancer	5.44e-05	0.000392	CcSEcCtD
Pimozide—Nausea—Irinotecan—breast cancer	5.44e-05	0.000392	CcSEcCtD
Pimozide—Constipation—Docetaxel—breast cancer	5.42e-05	0.00039	CcSEcCtD
Pimozide—Visual impairment—Doxorubicin—breast cancer	5.36e-05	0.000386	CcSEcCtD
Pimozide—Asthenia—Paclitaxel—breast cancer	5.36e-05	0.000386	CcSEcCtD
Pimozide—Decreased appetite—Capecitabine—breast cancer	5.33e-05	0.000384	CcSEcCtD
Pimozide—Nausea—Gemcitabine—breast cancer	5.3e-05	0.000382	CcSEcCtD
Pimozide—Gastrointestinal disorder—Capecitabine—breast cancer	5.29e-05	0.000381	CcSEcCtD
Pimozide—Pruritus—Paclitaxel—breast cancer	5.29e-05	0.000381	CcSEcCtD
Pimozide—Vision blurred—Methotrexate—breast cancer	5.27e-05	0.00038	CcSEcCtD
Pimozide—Mental disorder—Epirubicin—breast cancer	5.27e-05	0.000379	CcSEcCtD
Pimozide—Constipation—Capecitabine—breast cancer	5.24e-05	0.000378	CcSEcCtD
Pimozide—Nausea—Fluorouracil—breast cancer	5.21e-05	0.000375	CcSEcCtD
Pimozide—Eye disorder—Doxorubicin—breast cancer	5.2e-05	0.000374	CcSEcCtD
Pimozide—Anaemia—Methotrexate—breast cancer	5.17e-05	0.000372	CcSEcCtD
Pimozide—Cardiac disorder—Doxorubicin—breast cancer	5.16e-05	0.000372	CcSEcCtD
Pimozide—Diarrhoea—Paclitaxel—breast cancer	5.11e-05	0.000368	CcSEcCtD
Pimozide—Muscle spasms—Epirubicin—breast cancer	5.03e-05	0.000362	CcSEcCtD
Pimozide—Leukopenia—Methotrexate—breast cancer	5.01e-05	0.000361	CcSEcCtD
Pimozide—Dizziness—Paclitaxel—breast cancer	4.94e-05	0.000356	CcSEcCtD
Pimozide—Vision blurred—Epirubicin—breast cancer	4.93e-05	0.000355	CcSEcCtD
Pimozide—Mental disorder—Doxorubicin—breast cancer	4.87e-05	0.000351	CcSEcCtD
Pimozide—Urticaria—Capecitabine—breast cancer	4.87e-05	0.000351	CcSEcCtD
Pimozide—Convulsion—Methotrexate—breast cancer	4.85e-05	0.000349	CcSEcCtD
Pimozide—Anaemia—Epirubicin—breast cancer	4.84e-05	0.000348	CcSEcCtD
Pimozide—Agitation—Epirubicin—breast cancer	4.81e-05	0.000346	CcSEcCtD
Pimozide—Myalgia—Methotrexate—breast cancer	4.76e-05	0.000343	CcSEcCtD
Pimozide—Chest pain—Methotrexate—breast cancer	4.76e-05	0.000343	CcSEcCtD
Pimozide—Vomiting—Paclitaxel—breast cancer	4.75e-05	0.000342	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.73e-05	0.000341	CcSEcCtD
Pimozide—Rash—Paclitaxel—breast cancer	4.71e-05	0.000339	CcSEcCtD
Pimozide—Dermatitis—Paclitaxel—breast cancer	4.71e-05	0.000339	CcSEcCtD
Pimozide—Syncope—Epirubicin—breast cancer	4.69e-05	0.000338	CcSEcCtD
Pimozide—Leukopenia—Epirubicin—breast cancer	4.68e-05	0.000337	CcSEcCtD
Pimozide—Headache—Paclitaxel—breast cancer	4.68e-05	0.000337	CcSEcCtD
Pimozide—Muscle spasms—Doxorubicin—breast cancer	4.66e-05	0.000335	CcSEcCtD
Pimozide—Palpitations—Epirubicin—breast cancer	4.62e-05	0.000333	CcSEcCtD
Pimozide—Loss of consciousness—Epirubicin—breast cancer	4.6e-05	0.000331	CcSEcCtD
Pimozide—Vision blurred—Doxorubicin—breast cancer	4.56e-05	0.000329	CcSEcCtD
Pimozide—Asthenia—Docetaxel—breast cancer	4.54e-05	0.000327	CcSEcCtD
Pimozide—Convulsion—Epirubicin—breast cancer	4.53e-05	0.000327	CcSEcCtD
Pimozide—Hypertension—Epirubicin—breast cancer	4.52e-05	0.000325	CcSEcCtD
Pimozide—Pruritus—Docetaxel—breast cancer	4.48e-05	0.000323	CcSEcCtD
Pimozide—Nervous system disorder—Methotrexate—breast cancer	4.48e-05	0.000322	CcSEcCtD
Pimozide—Anaemia—Doxorubicin—breast cancer	4.48e-05	0.000322	CcSEcCtD
Pimozide—Chest pain—Epirubicin—breast cancer	4.46e-05	0.000321	CcSEcCtD
Pimozide—Myalgia—Epirubicin—breast cancer	4.46e-05	0.000321	CcSEcCtD
Pimozide—Agitation—Doxorubicin—breast cancer	4.45e-05	0.000321	CcSEcCtD
Pimozide—Nausea—Paclitaxel—breast cancer	4.44e-05	0.00032	CcSEcCtD
Pimozide—Skin disorder—Methotrexate—breast cancer	4.43e-05	0.000319	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.42e-05	0.000319	CcSEcCtD
Pimozide—Hyperhidrosis—Methotrexate—breast cancer	4.41e-05	0.000318	CcSEcCtD
Pimozide—Asthenia—Capecitabine—breast cancer	4.4e-05	0.000317	CcSEcCtD
Pimozide—Dry mouth—Epirubicin—breast cancer	4.36e-05	0.000314	CcSEcCtD
Pimozide—Anorexia—Methotrexate—breast cancer	4.35e-05	0.000313	CcSEcCtD
Pimozide—Syncope—Doxorubicin—breast cancer	4.34e-05	0.000313	CcSEcCtD
Pimozide—Pruritus—Capecitabine—breast cancer	4.34e-05	0.000312	CcSEcCtD
Pimozide—Leukopenia—Doxorubicin—breast cancer	4.33e-05	0.000312	CcSEcCtD
Pimozide—Diarrhoea—Docetaxel—breast cancer	4.33e-05	0.000312	CcSEcCtD
Pimozide—Palpitations—Doxorubicin—breast cancer	4.28e-05	0.000308	CcSEcCtD
Pimozide—Hypotension—Methotrexate—breast cancer	4.26e-05	0.000307	CcSEcCtD
Pimozide—Loss of consciousness—Doxorubicin—breast cancer	4.26e-05	0.000307	CcSEcCtD
Pimozide—Shock—Epirubicin—breast cancer	4.2e-05	0.000303	CcSEcCtD
Pimozide—Convulsion—Doxorubicin—breast cancer	4.2e-05	0.000302	CcSEcCtD
Pimozide—Diarrhoea—Capecitabine—breast cancer	4.19e-05	0.000302	CcSEcCtD
Pimozide—Nervous system disorder—Epirubicin—breast cancer	4.19e-05	0.000302	CcSEcCtD
Pimozide—Dizziness—Docetaxel—breast cancer	4.19e-05	0.000302	CcSEcCtD
Pimozide—Hypertension—Doxorubicin—breast cancer	4.18e-05	0.000301	CcSEcCtD
Pimozide—Tachycardia—Epirubicin—breast cancer	4.17e-05	0.0003	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Methotrexate—breast cancer	4.16e-05	0.0003	CcSEcCtD
Pimozide—Skin disorder—Epirubicin—breast cancer	4.15e-05	0.000299	CcSEcCtD
Pimozide—Hyperhidrosis—Epirubicin—breast cancer	4.13e-05	0.000297	CcSEcCtD
Pimozide—Insomnia—Methotrexate—breast cancer	4.13e-05	0.000297	CcSEcCtD
Pimozide—Chest pain—Doxorubicin—breast cancer	4.12e-05	0.000297	CcSEcCtD
Pimozide—Myalgia—Doxorubicin—breast cancer	4.12e-05	0.000297	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.09e-05	0.000295	CcSEcCtD
Pimozide—Anorexia—Epirubicin—breast cancer	4.07e-05	0.000293	CcSEcCtD
Pimozide—Somnolence—Methotrexate—breast cancer	4.06e-05	0.000292	CcSEcCtD
Pimozide—Dizziness—Capecitabine—breast cancer	4.05e-05	0.000292	CcSEcCtD
Pimozide—Dry mouth—Doxorubicin—breast cancer	4.03e-05	0.00029	CcSEcCtD
Pimozide—Vomiting—Docetaxel—breast cancer	4.03e-05	0.00029	CcSEcCtD
Pimozide—Rash—Docetaxel—breast cancer	3.99e-05	0.000288	CcSEcCtD
Pimozide—Hypotension—Epirubicin—breast cancer	3.99e-05	0.000287	CcSEcCtD
Pimozide—Dermatitis—Docetaxel—breast cancer	3.99e-05	0.000287	CcSEcCtD
Pimozide—Decreased appetite—Methotrexate—breast cancer	3.97e-05	0.000286	CcSEcCtD
Pimozide—Headache—Docetaxel—breast cancer	3.97e-05	0.000286	CcSEcCtD
Pimozide—Gastrointestinal disorder—Methotrexate—breast cancer	3.94e-05	0.000284	CcSEcCtD
Pimozide—Vomiting—Capecitabine—breast cancer	3.9e-05	0.000281	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Epirubicin—breast cancer	3.89e-05	0.00028	CcSEcCtD
Pimozide—Shock—Doxorubicin—breast cancer	3.89e-05	0.00028	CcSEcCtD
Pimozide—Nervous system disorder—Doxorubicin—breast cancer	3.88e-05	0.000279	CcSEcCtD
Pimozide—Rash—Capecitabine—breast cancer	3.87e-05	0.000278	CcSEcCtD
Pimozide—Insomnia—Epirubicin—breast cancer	3.86e-05	0.000278	CcSEcCtD
Pimozide—Dermatitis—Capecitabine—breast cancer	3.86e-05	0.000278	CcSEcCtD
Pimozide—Tachycardia—Doxorubicin—breast cancer	3.86e-05	0.000278	CcSEcCtD
Pimozide—Headache—Capecitabine—breast cancer	3.84e-05	0.000277	CcSEcCtD
Pimozide—Skin disorder—Doxorubicin—breast cancer	3.84e-05	0.000277	CcSEcCtD
Pimozide—Hyperhidrosis—Doxorubicin—breast cancer	3.82e-05	0.000275	CcSEcCtD
Pimozide—Somnolence—Epirubicin—breast cancer	3.8e-05	0.000274	CcSEcCtD
Pimozide—Anorexia—Doxorubicin—breast cancer	3.77e-05	0.000271	CcSEcCtD
Pimozide—Nausea—Docetaxel—breast cancer	3.76e-05	0.000271	CcSEcCtD
Pimozide—Decreased appetite—Epirubicin—breast cancer	3.71e-05	0.000267	CcSEcCtD
Pimozide—Hypotension—Doxorubicin—breast cancer	3.69e-05	0.000266	CcSEcCtD
Pimozide—Gastrointestinal disorder—Epirubicin—breast cancer	3.69e-05	0.000266	CcSEcCtD
Pimozide—Constipation—Epirubicin—breast cancer	3.65e-05	0.000263	CcSEcCtD
Pimozide—Nausea—Capecitabine—breast cancer	3.64e-05	0.000262	CcSEcCtD
Pimozide—Urticaria—Methotrexate—breast cancer	3.63e-05	0.000261	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.6e-05	0.000259	CcSEcCtD
Pimozide—Insomnia—Doxorubicin—breast cancer	3.57e-05	0.000257	CcSEcCtD
Pimozide—Somnolence—Doxorubicin—breast cancer	3.51e-05	0.000253	CcSEcCtD
Pimozide—Decreased appetite—Doxorubicin—breast cancer	3.44e-05	0.000247	CcSEcCtD
Pimozide—Gastrointestinal disorder—Doxorubicin—breast cancer	3.41e-05	0.000246	CcSEcCtD
Pimozide—Urticaria—Epirubicin—breast cancer	3.39e-05	0.000244	CcSEcCtD
Pimozide—Constipation—Doxorubicin—breast cancer	3.38e-05	0.000243	CcSEcCtD
Pimozide—Asthenia—Methotrexate—breast cancer	3.27e-05	0.000236	CcSEcCtD
Pimozide—Pruritus—Methotrexate—breast cancer	3.23e-05	0.000233	CcSEcCtD
Pimozide—Urticaria—Doxorubicin—breast cancer	3.14e-05	0.000226	CcSEcCtD
Pimozide—Diarrhoea—Methotrexate—breast cancer	3.12e-05	0.000225	CcSEcCtD
Pimozide—Asthenia—Epirubicin—breast cancer	3.06e-05	0.000221	CcSEcCtD
Pimozide—Pruritus—Epirubicin—breast cancer	3.02e-05	0.000218	CcSEcCtD
Pimozide—Dizziness—Methotrexate—breast cancer	3.02e-05	0.000217	CcSEcCtD
Pimozide—Diarrhoea—Epirubicin—breast cancer	2.92e-05	0.000211	CcSEcCtD
Pimozide—Vomiting—Methotrexate—breast cancer	2.9e-05	0.000209	CcSEcCtD
Pimozide—Rash—Methotrexate—breast cancer	2.88e-05	0.000207	CcSEcCtD
Pimozide—Dermatitis—Methotrexate—breast cancer	2.88e-05	0.000207	CcSEcCtD
Pimozide—Headache—Methotrexate—breast cancer	2.86e-05	0.000206	CcSEcCtD
Pimozide—Asthenia—Doxorubicin—breast cancer	2.84e-05	0.000204	CcSEcCtD
Pimozide—Dizziness—Epirubicin—breast cancer	2.82e-05	0.000203	CcSEcCtD
Pimozide—Pruritus—Doxorubicin—breast cancer	2.8e-05	0.000201	CcSEcCtD
Pimozide—Vomiting—Epirubicin—breast cancer	2.72e-05	0.000196	CcSEcCtD
Pimozide—Nausea—Methotrexate—breast cancer	2.71e-05	0.000195	CcSEcCtD
Pimozide—Diarrhoea—Doxorubicin—breast cancer	2.7e-05	0.000195	CcSEcCtD
Pimozide—Rash—Epirubicin—breast cancer	2.69e-05	0.000194	CcSEcCtD
Pimozide—Dermatitis—Epirubicin—breast cancer	2.69e-05	0.000194	CcSEcCtD
Pimozide—Headache—Epirubicin—breast cancer	2.68e-05	0.000193	CcSEcCtD
Pimozide—Dizziness—Doxorubicin—breast cancer	2.61e-05	0.000188	CcSEcCtD
Pimozide—Nausea—Epirubicin—breast cancer	2.54e-05	0.000183	CcSEcCtD
Pimozide—Vomiting—Doxorubicin—breast cancer	2.51e-05	0.000181	CcSEcCtD
Pimozide—Rash—Doxorubicin—breast cancer	2.49e-05	0.000179	CcSEcCtD
Pimozide—Dermatitis—Doxorubicin—breast cancer	2.49e-05	0.000179	CcSEcCtD
Pimozide—Headache—Doxorubicin—breast cancer	2.48e-05	0.000178	CcSEcCtD
Pimozide—Nausea—Doxorubicin—breast cancer	2.35e-05	0.000169	CcSEcCtD
Pimozide—CALM1—Signaling Pathways—RAF1—breast cancer	1.03e-06	7.53e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—RAF1—breast cancer	1.03e-06	7.53e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.03e-06	7.53e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—TGFB1—breast cancer	1.03e-06	7.52e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—TGFB1—breast cancer	1.03e-06	7.52e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—RELA—breast cancer	1.02e-06	7.5e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—RELA—breast cancer	1.02e-06	7.5e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—PIK3CA—breast cancer	1.02e-06	7.49e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—NOS3—breast cancer	1.02e-06	7.47e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GSTM1—breast cancer	1.02e-06	7.46e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—NCOR1—breast cancer	1.02e-06	7.46e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.02e-06	7.46e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—SRC—breast cancer	1.02e-06	7.46e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ERBB2—breast cancer	1.02e-06	7.45e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ERBB2—breast cancer	1.02e-06	7.45e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CD—breast cancer	1.02e-06	7.45e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—EGFR—breast cancer	1.02e-06	7.45e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—PIK3CA—breast cancer	1.01e-06	7.42e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—EGFR—breast cancer	1.01e-06	7.38e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—EGFR—breast cancer	1.01e-06	7.38e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MTOR—breast cancer	1e-06	7.35e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MTOR—breast cancer	1e-06	7.35e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CB—breast cancer	1e-06	7.35e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CB—breast cancer	1e-06	7.35e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ALB—breast cancer	1e-06	7.35e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—SRC—breast cancer	1e-06	7.34e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—SRC—breast cancer	9.99e-07	7.32e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CXCL8—breast cancer	9.97e-07	7.31e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—breast cancer	9.91e-07	7.27e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—HRAS—breast cancer	9.9e-07	7.26e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—breast cancer	9.88e-07	7.24e-06	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—AKT1—breast cancer	9.87e-07	7.24e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—SRC—breast cancer	9.83e-07	7.21e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—KRAS—breast cancer	9.83e-07	7.2e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—STAT3—breast cancer	9.81e-07	7.19e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CG—breast cancer	9.79e-07	7.18e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—breast cancer	9.78e-07	7.17e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—PIK3CA—breast cancer	9.78e-07	7.17e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—breast cancer	9.75e-07	7.15e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GPX1—breast cancer	9.75e-07	7.15e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CDKN1B—breast cancer	9.73e-07	7.14e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—breast cancer	9.73e-07	7.13e-06	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—AKT1—breast cancer	9.73e-07	7.13e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—STAT3—breast cancer	9.65e-07	7.08e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CYP1A1—breast cancer	9.65e-07	7.07e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CXCL8—breast cancer	9.64e-07	7.07e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CXCL8—breast cancer	9.64e-07	7.07e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—STAT3—breast cancer	9.63e-07	7.06e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CB—breast cancer	9.63e-07	7.06e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—NOS3—breast cancer	9.6e-07	7.03e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—KRAS—breast cancer	9.59e-07	7.03e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—HRAS—breast cancer	9.58e-07	7.02e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—HRAS—breast cancer	9.58e-07	7.02e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—breast cancer	9.57e-07	7.02e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ERCC2—breast cancer	9.57e-07	7.02e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTGS2—breast cancer	9.54e-07	7e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CASP3—breast cancer	9.54e-07	6.99e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2—breast cancer	9.52e-07	6.98e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—KRAS—breast cancer	9.51e-07	6.97e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—KRAS—breast cancer	9.51e-07	6.97e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—STAT3—breast cancer	9.48e-07	6.95e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6—breast cancer	9.48e-07	6.95e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—PIK3CA—breast cancer	9.46e-07	6.93e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—PIK3CA—breast cancer	9.46e-07	6.93e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—HRAS—breast cancer	9.45e-07	6.93e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CDKN1B—breast cancer	9.41e-07	6.9e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CDKN1B—breast cancer	9.41e-07	6.9e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CB—breast cancer	9.4e-07	6.89e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MAPK3—breast cancer	9.37e-07	6.87e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—HRAS—breast cancer	9.36e-07	6.86e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTGS2—breast cancer	9.31e-07	6.83e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCND1—breast cancer	9.28e-07	6.81e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—JUN—breast cancer	9.26e-07	6.79e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CASP3—breast cancer	9.23e-07	6.76e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CASP3—breast cancer	9.23e-07	6.76e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MAPK3—breast cancer	9.22e-07	6.76e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2—breast cancer	9.21e-07	6.75e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL2—breast cancer	9.21e-07	6.75e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MAPK3—breast cancer	9.2e-07	6.75e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CTNNB1—breast cancer	9.19e-07	6.74e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6—breast cancer	9.17e-07	6.72e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6—breast cancer	9.17e-07	6.72e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MYC—breast cancer	9.12e-07	6.68e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TGFB1—breast cancer	9.09e-07	6.67e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MAPK3—breast cancer	9.06e-07	6.64e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—HRAS—breast cancer	9.05e-07	6.63e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6—breast cancer	9.04e-07	6.63e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—PIK3CA—breast cancer	9.03e-07	6.62e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MMP9—breast cancer	9.01e-07	6.61e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—MTHFR—breast cancer	8.99e-07	6.59e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CDKN1A—breast cancer	8.98e-07	6.58e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCND1—breast cancer	8.98e-07	6.58e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCND1—breast cancer	8.98e-07	6.58e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MYC—breast cancer	8.97e-07	6.58e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—JUN—breast cancer	8.96e-07	6.57e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—JUN—breast cancer	8.96e-07	6.57e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PTEN—breast cancer	8.96e-07	6.57e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6—breast cancer	8.96e-07	6.57e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MYC—breast cancer	8.95e-07	6.56e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TGFB1—breast cancer	8.95e-07	6.56e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TGFB1—breast cancer	8.93e-07	6.55e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—EGFR—breast cancer	8.92e-07	6.54e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CTNNB1—breast cancer	8.89e-07	6.52e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CTNNB1—breast cancer	8.89e-07	6.52e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CB—breast cancer	8.86e-07	6.49e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—PIK3CA—breast cancer	8.81e-07	6.46e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MYC—breast cancer	8.81e-07	6.46e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TGFB1—breast cancer	8.79e-07	6.44e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTGS2—breast cancer	8.78e-07	6.43e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EGFR—breast cancer	8.77e-07	6.43e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MAPK8—breast cancer	8.77e-07	6.43e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EGFR—breast cancer	8.76e-07	6.42e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—HRAS—breast cancer	8.75e-07	6.42e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—HRAS—breast cancer	8.75e-07	6.42e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—AKT1—breast cancer	8.74e-07	6.41e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—PIK3CA—breast cancer	8.73e-07	6.4e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—PIK3CA—breast cancer	8.73e-07	6.4e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MMP9—breast cancer	8.72e-07	6.39e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MMP9—breast cancer	8.72e-07	6.39e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CDKN1A—breast cancer	8.69e-07	6.37e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CDKN1A—breast cancer	8.69e-07	6.37e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PTEN—breast cancer	8.67e-07	6.36e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PTEN—breast cancer	8.67e-07	6.36e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6—breast cancer	8.66e-07	6.35e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EGFR—breast cancer	8.62e-07	6.32e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CD—breast cancer	8.61e-07	6.31e-06	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—AKT1—breast cancer	8.58e-07	6.29e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—breast cancer	8.53e-07	6.25e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ALB—breast cancer	8.5e-07	6.23e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MAPK8—breast cancer	8.48e-07	6.22e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MAPK8—breast cancer	8.48e-07	6.22e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—AKT1—breast cancer	8.46e-07	6.2e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—AKT1—breast cancer	8.46e-07	6.2e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—KRAS—breast cancer	8.42e-07	6.18e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6—breast cancer	8.38e-07	6.14e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6—breast cancer	8.38e-07	6.14e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—HRAS—breast cancer	8.35e-07	6.12e-06	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—AKT1—breast cancer	8.34e-07	6.12e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTEN—breast cancer	8.32e-07	6.1e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SRC—breast cancer	8.31e-07	6.09e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CAV1—breast cancer	8.3e-07	6.08e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—KRAS—breast cancer	8.29e-07	6.08e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—KRAS—breast cancer	8.27e-07	6.06e-06	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—AKT1—breast cancer	8.26e-07	6.06e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—HRAS—breast cancer	8.16e-07	5.98e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—KRAS—breast cancer	8.14e-07	5.97e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—NOS3—breast cancer	8.13e-07	5.96e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTEN—breast cancer	8.12e-07	5.95e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—breast cancer	8.09e-07	5.93e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—HRAS—breast cancer	8.08e-07	5.92e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—HRAS—breast cancer	8.08e-07	5.92e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SRC—breast cancer	8.04e-07	5.89e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SRC—breast cancer	8.04e-07	5.89e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—STAT3—breast cancer	8.01e-07	5.88e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6—breast cancer	7.99e-07	5.86e-06	CbGpPWpGaD
Pimozide—CALM3—Immune System—AKT1—breast cancer	7.99e-07	5.86e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—breast cancer	7.83e-07	5.74e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—breast cancer	7.83e-07	5.74e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6—breast cancer	7.81e-07	5.72e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—STAT3—breast cancer	7.75e-07	5.68e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—STAT3—breast cancer	7.75e-07	5.68e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—PIK3CA—breast cancer	7.74e-07	5.67e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6—breast cancer	7.73e-07	5.67e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6—breast cancer	7.73e-07	5.67e-06	CbGpPWpGaD
Pimozide—CALM2—Immune System—AKT1—breast cancer	7.73e-07	5.66e-06	CbGpPWpGaD
Pimozide—CALM1—Immune System—AKT1—breast cancer	7.73e-07	5.66e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MAPK3—breast cancer	7.66e-07	5.61e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTEN—breast cancer	7.65e-07	5.61e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—PIK3CA—breast cancer	7.62e-07	5.58e-06	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PIK3CA—breast cancer	7.61e-07	5.58e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—PIK3CA—breast cancer	7.6e-07	5.57e-06	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PIK3CA—breast cancer	7.59e-07	5.57e-06	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PIK3CA—breast cancer	7.56e-07	5.54e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CG—breast cancer	7.56e-07	5.54e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CB—breast cancer	7.5e-07	5.5e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—breast cancer	7.49e-07	5.49e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—PIK3CA—breast cancer	7.48e-07	5.48e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MYC—breast cancer	7.45e-07	5.46e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTGS2—breast cancer	7.43e-07	5.45e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TGFB1—breast cancer	7.43e-07	5.45e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MAPK3—breast cancer	7.41e-07	5.43e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MAPK3—breast cancer	7.41e-07	5.43e-06	CbGpPWpGaD
Pimozide—CALM3—Disease—AKT1—breast cancer	7.37e-07	5.41e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—breast cancer	7.37e-07	5.4e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—breast cancer	7.35e-07	5.39e-06	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PIK3CA—breast cancer	7.31e-07	5.36e-06	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PIK3CA—breast cancer	7.31e-07	5.36e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EGFR—breast cancer	7.28e-07	5.34e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—breast cancer	7.23e-07	5.3e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MYC—breast cancer	7.2e-07	5.28e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MYC—breast cancer	7.2e-07	5.28e-06	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—AKT1—breast cancer	7.2e-07	5.28e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TGFB1—breast cancer	7.19e-07	5.27e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TGFB1—breast cancer	7.19e-07	5.27e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—HRAS—breast cancer	7.16e-07	5.25e-06	CbGpPWpGaD
Pimozide—CALM2—Disease—AKT1—breast cancer	7.13e-07	5.23e-06	CbGpPWpGaD
Pimozide—CALM1—Disease—AKT1—breast cancer	7.13e-07	5.23e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EGFR—breast cancer	7.05e-07	5.17e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EGFR—breast cancer	7.05e-07	5.17e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—HRAS—breast cancer	7.05e-07	5.17e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—HRAS—breast cancer	7.03e-07	5.15e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—HRAS—breast cancer	6.92e-07	5.07e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—KRAS—breast cancer	6.88e-07	5.04e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6—breast cancer	6.85e-07	5.02e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6—breast cancer	6.74e-07	4.94e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6—breast cancer	6.73e-07	4.93e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—KRAS—breast cancer	6.66e-07	4.88e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—KRAS—breast cancer	6.66e-07	4.88e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CD—breast cancer	6.64e-07	4.87e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6—breast cancer	6.62e-07	4.85e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ALB—breast cancer	6.56e-07	4.81e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTEN—breast cancer	6.48e-07	4.75e-06	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—AKT1—breast cancer	6.32e-07	4.64e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—PIK3CA—breast cancer	6.32e-07	4.63e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—NOS3—breast cancer	6.27e-07	4.6e-06	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—AKT1—breast cancer	6.22e-07	4.56e-06	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—AKT1—breast cancer	6.22e-07	4.56e-06	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—AKT1—breast cancer	6.21e-07	4.55e-06	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—AKT1—breast cancer	6.2e-07	4.55e-06	CbGpPWpGaD
Pimozide—CALM3—Metabolism—AKT1—breast cancer	6.18e-07	4.53e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—breast cancer	6.12e-07	4.48e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CA—breast cancer	6.12e-07	4.48e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CA—breast cancer	6.12e-07	4.48e-06	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—AKT1—breast cancer	6.11e-07	4.48e-06	CbGpPWpGaD
Pimozide—CALM1—Metabolism—AKT1—breast cancer	5.97e-07	4.38e-06	CbGpPWpGaD
Pimozide—CALM2—Metabolism—AKT1—breast cancer	5.97e-07	4.38e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—breast cancer	5.92e-07	4.34e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—breast cancer	5.92e-07	4.34e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CA—breast cancer	5.87e-07	4.3e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—HRAS—breast cancer	5.85e-07	4.29e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CB—breast cancer	5.79e-07	4.25e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTGS2—breast cancer	5.74e-07	4.21e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CA—breast cancer	5.73e-07	4.2e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HRAS—breast cancer	5.66e-07	4.15e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HRAS—breast cancer	5.66e-07	4.15e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6—breast cancer	5.6e-07	4.1e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6—breast cancer	5.41e-07	3.97e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6—breast cancer	5.41e-07	3.97e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CA—breast cancer	5.4e-07	3.96e-06	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—AKT1—breast cancer	5.16e-07	3.79e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTEN—breast cancer	5e-07	3.67e-06	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AKT1—breast cancer	5e-07	3.66e-06	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AKT1—breast cancer	5e-07	3.66e-06	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—AKT1—breast cancer	4.8e-07	3.52e-06	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—AKT1—breast cancer	4.68e-07	3.43e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CA—breast cancer	4.57e-07	3.35e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—AKT1—breast cancer	4.41e-07	3.23e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—AKT1—breast cancer	3.74e-07	2.74e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CA—breast cancer	3.53e-07	2.59e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AKT1—breast cancer	2.88e-07	2.11e-06	CbGpPWpGaD
